Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
RWT
12576
CALL
Redwood Trust
RWT
$432M
| $39.8K | ﹤0.01% |
6,100
-22,600
| -79% | -$163K |
2019 Q4
20 quarters
|
|
12577
Wave Life Sciences
WVE
$694M
| $39.8K | ﹤0.01% |
3,218
-934,368
| -100% | -$12.5M |
2023 Q4
4 quarters
|
|
12578
Inovio Pharmaceuticals
INO
$117M
| $39.8K | ﹤0.01% |
+21,728
| New | +$96.2K |
2024 Q4
0 quarters
|
|
12579
CALL
Ultrapar
UGP
$8.25B
| $39.7K | ﹤0.01% |
15,100
+10,600
| +236% | +$35.1K |
2024 Q3
1 quarter
|
|
12580
PUT
iShares Core MSCI Total International Stock ETF
IXUS
$59.4B
| $39.7K | ﹤0.01% |
600
-1,600
| -73% | -$111K |
2024 Q3
1 quarter
|
|
12581
CALL
First Internet Bancorp
INBK
$233M
| $39.6K | ﹤0.01% |
1,100
-3,600
| -77% | -$137K |
2022 Q4
8 quarters
|
|
12582
CEMIG Ordinary Shares
CIG.C
$10B
| $39.6K | ﹤0.01% |
+17,058
| New | +$42.1K |
2024 Q4
0 quarters
|
|
|
KNDI
12583
CALL
Kandi Technologies Group
KNDI
$71.6M
| $39.5K | ﹤0.01% |
32,900
+6,300
| +24% | +$8.2K |
2013 Q2
46 quarters
|
|
|
ADAM
12584
PUT
Adamas Trust
ADAM
$694M
| $39.4K | ﹤0.01% |
6,500
+1,700
| +35% | +$9.99K |
2017 Q4
28 quarters
|
|
12585
CALL
John Wiley & Sons Class A
WLY
$2.46B
| $39.3K | ﹤0.01% |
900
-7,800
| -90% | -$383K |
2022 Q4
8 quarters
|
|
12586
Willamette Valley Vineyards
WVVI
$9.31M
| $39.3K | ﹤0.01% |
+11,726
| New | +$39.7K |
2024 Q4
0 quarters
|
|
12587
PUT
Ivanhoe Electric
IE
$1.66B
| $39.3K | ﹤0.01% |
5,200
-8,600
| -62% | -$79.5K |
2023 Q4
4 quarters
|
|
12588
PUT
StoneX
SNEX
$7.96B
| $39.2K | ﹤0.01% |
+1,350
| New | +$37.8K |
2024 Q4
0 quarters
|
|
12589
PUT
Blend Labs
BLND
$241M
| $39.2K | ﹤0.01% |
9,300
-15,600
| -63% | -$67.1K |
2023 Q4
4 quarters
|
|
12590
CALL
American Well
AMWL
$209M
| $39.1K | ﹤0.01% |
+5,400
| New | +$48.9K |
2024 Q4
0 quarters
|
|
|
RDNW
12591
CALL
RideNow Group
RDNW
$190M
| $39.1K | ﹤0.01% |
7,200
-10,500
| -59% | -$58.2K |
2022 Q1
11 quarters
|
|
|
QQQH
12592
CALL
NEOS Nasdaq-100 Hedged Equity Income ETF
QQQH
$413M
| $39.1K | ﹤0.01% |
750
-350
| -32% | -$18.2K |
2021 Q4
12 quarters
|
|
12593
CALL
Xencor
XNCR
$1.81B
| $39.1K | ﹤0.01% |
1,700
-800
| -32% | -$18.4K |
2022 Q4
8 quarters
|
|
|
ADAM
12594
Adamas Trust
ADAM
$694M
| $39K | ﹤0.01% |
6,437
-29,485
| -82% | -$173K |
2015 Q3
37 quarters
|
|
12595
PUT
Interface
TILE
$2.03B
| $39K | ﹤0.01% |
1,600
+500
| +45% | +$11.5K |
2022 Q3
9 quarters
|
|
|
VSTA
12596
DELISTED
Vasta Platform
VSTA
| $38.9K | ﹤0.01% |
19,448
-2,906
| -13% | -$7.12K |
2024 Q1
3 quarters
|
|
12597
PUT
Orion Group Holdings
ORN
$379M
| $38.8K | ﹤0.01% |
5,300
+5,200
| +5,200% | +$37.6K |
2022 Q4
8 quarters
|
|
12598
Sabre
SABR
$775M
| $38.8K | ﹤0.01% |
10,637
-1,457,378
| -99% | -$5.34M |
2017 Q1
31 quarters
|
|
12599
CALL
Neuronetics
STIM
$168M
| $38.8K | ﹤0.01% |
24,100
-6,000
| -20% | -$6.24K |
2024 Q3
1 quarter
|
|
12600
CNS Pharmaceuticals
CNSP
$7.75M
| $38.8K | ﹤0.01% |
+536
| New | +$38.1K |
2024 Q4
0 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.